EmeraMed Ltd is a biotechnology firm developing the lipophilic, blood-brain-barrier passing metal chelator and antioxidant Irminix®


EmeraMed Limited is a privately held limited liability company (corporation) organized and headquartered in the Republic of Ireland. The Company currently operates in Ireland, Sweden and the United States. The Company’s owner group is primarily composed of physicians, dentists, and patients with personal experience of the product from when it was previously sold as a dietary supplement. If you are interested in learning more about the Company, please use our Contact page to request additional information.

This information is provided for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security in any jurisdiction.